title: Vaccine herd effect.
abstract: Vaccination ideally protects susceptible populations at high risk for complications of the infection. However, vaccines for these subgroups do not always provide sufficient effectiveness. The herd effect or herd immunity is an attractive way to extend vaccine benefits beyond the directly targeted population. It refers to the indirect protection of unvaccinated persons, whereby an increase in the prevalence of immunity by the vaccine prevents circulation of infectious agents in susceptible populations. The herd effect has had a major impact in the eradication of smallpox, has reduced transmission of pertussis, and protects against influenza and pneumococcal disease. A high uptake of vaccines is generally needed for success. In this paper we aim to provide an update review on the herd effect, focusing on the clinical benefit, by reviewing data for specific vaccines.
authors: Department of Pathology and Molecular Medicine, McMaster University, 1280 Main Street West, Hamilton, Ontario, Canada.
authors: Tae Hyong
authors: TH
authors: Kim
authors: Jennie
authors: J
authors: Johnstone
authors: Mark
authors: M
authors: Loeb
references: J Leukoc Biol. 2010 Jun;87(6):1001-9
references: 20200405
references: JAMA. 1977 Dec 12;238(24):2613-6
references: 21973
references: N Engl J Med. 2005 Mar 24;352(12):1215-22
references: 15788498
references: Semin Respir Crit Care Med. 2009 Apr;30(2):189-209
references: 19296419
references: J Infect Dis. 2009 Nov 1;200 Suppl 1:S125-30
references: 19821709
references: J Infect Dis. 1970 Jul-Aug;122(1):16-25
references: 5433709
references: Clin Infect Dis. 1999 Jun;28(6):1230-7
references: 10451158
references: Epidemiol Infect. 2010 Jun;138(6):884-97
references: 20028612
references: BMJ. 2003 Feb 15;326(7385):365-6
references: 12586669
references: Lancet. 1986 Sep 6;2(8506):555-8
references: 2875290
references: J Infect Dis. 2009 Nov 1;200 Suppl 1:S9-S15
references: 19817620
references: Am J Epidemiol. 1991 Feb 15;133(4):323-31
references: 1899778
references: N Engl J Med. 2006 Jan 5;354(1):23-33
references: 16394299
references: Lancet Infect Dis. 2006 Feb;6(2):112-7
references: 16439331
references: Epidemiol Rev. 2006;28:88-100
references: 16740585
references: Wkly Epidemiol Rec. 2008 Oct 17;83(42):373-84
references: 18927997
references: Lancet. 2009 Jul 25;374(9686):301-14
references: 19586656
references: Infect Control Hosp Epidemiol. 2010 Oct;31(10):987-95
references: 20807037
references: Lancet. 2005 Oct 1;366(9492):1165-74
references: 16198765
references: Lancet Infect Dis. 2007 Jul;7(7):453-9
references: 17597569
references: JAMA. 2010 Mar 10;303(10):943-50
references: 20215608
references: Clin Vaccine Immunol. 2009 Mar;16(3):382-6
references: 19158283
references: MMWR Recomm Rep. 2011 Jan 28;60(2):1-64
references: 21293327
references: Curr Top Microbiol Immunol. 2006;304:17-29
references: 16989262
references: PLoS Med. 2008 Oct 28;5(10):e200
references: 18959470
references: CMAJ. 2007 Aug 28;177(5):469-79
references: 17671238
references: Pediatr Infect Dis J. 2003 Jan;22(1):22-7
references: 12544404
references: Clin Infect Dis. 2010 Jan 15;50(2):184-91
references: 20001736
references: Clin Infect Dis. 2010 Feb 1;50(3):329-37
references: 20047478
references: Epidemiol Rev. 1996;18(1):64-76
references: 8877331
references: J Infect Dis. 1999 Jan;179(1):223-9
references: 9841843
references: JAMA. 2000 Oct 4;284(13):1677-82
references: 11015798
references: Lancet. 1991 Nov 2;338(8775):1093-6
references: 1682541
references: Lancet. 2005 Feb 26-Mar 4;365(9461):773-80
references: 15733718
references: Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000422
references: 18253977
references: FEMS Microbiol Rev. 2007 Jan;31(1):52-63
references: 17233635
references: NIPH Ann. 1980 Dec;3(2):9-22
references: 7219844
references: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references: 15761078
references: Cochrane Database Syst Rev. 2010 Feb 17;(2):CD005187
references: 20166073
references: Lancet. 2005 Sep 17-23;366(9490):991-8
references: 16168781
references: Clin Infect Dis. 2010 May 15;50(10):1339-45
references: 20370464
references: N Engl J Med. 2003 May 1;348(18):1737-46
references: 12724479
references: Med Health Care Philos. 2011 Feb;14(1):19-27
references: 20853152
references: Clin Infect Dis. 2008 Jan 1;46(1):1-13
references: 18171206
references: Wkly Epidemiol Rec. 2009 Jun 5;84(23):220-36
references: 19499606
references: Clin Infect Dis. 2001 Oct 1;33(7):1004-10
references: 11528572
references: Vaccine. 2006 Jun 5;24(23):4934-41
references: 16678945
references: CMAJ. 2009 Jan 6;180(1):48-58
references: 19124790
references: MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37
references: 17167397
references: N Engl J Med. 2006 Apr 6;354(14):1455-63
references: 16598044
references: Pediatr Infect Dis J. 2006 Jun;25(6):494-501
references: 16732146
references: N Engl J Med. 2005 Oct 13;353(15):1555-63
references: 16221778
references: JAMA. 2003 Jan 8;289(2):179-86
references: 12517228
references: Lancet. 2002 May 25;359(9320):1829-31
references: 12044380
references: MMWR Recomm Rep. 2005 May 27;54(RR-7):1-21
references: 15917737
references: Ann Allergy Asthma Immunol. 2010 Mar;104(3):183-90; quiz 190-2, 210
references: 20377107
references: N Engl J Med. 1996 Oct 3;335(14):1022-8
references: 8793926